BIOS Fund II, LP's Form 4 filing
IN8BIO, Inc. (INAB) · filed Aug 30, 2022
- Accession no.
- 0001104659-22-095951
- Filed
- Aug 30, 2022, 1:16 PM ET
- Trade date
- Aug 26-29, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 0 derivative transactions. Open-market purchases total $103.3K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| BIOS Fund II, LPCIK 0001714576 | Director, 10% Owner |
| BIOS Fund II QP, LPCIK 0001716869 | Director, 10% Owner |
| BIOS Fund II NT, LPCIK 0001728851 | Director, 10% Owner |
| BIOS Incysus Co-Invest I, LPCIK 0001740029 | Director, 10% Owner |
| Fletcher Aaron G.L.CIK 0001789490 | Director, 10% Owner |
| Cavu Management, LPCIK 0001813270 | Director, 10% Owner |
| Cavu Advisors, LLCCIK 0001813310 | Director, 10% Owner |
| Bios Equity Partners II, LPCIK 0001813313 | Director, 10% Owner |
| BIOS Equity Partners III, LPCIK 0001831976 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2022 | Common Stock | PPurchaseAcquired | +1,377 | $2.01 | +$2,767.77 | 584,784 | Indirect | Duplicate filing |
| Aug 29, 2022 | Common Stock | PPurchaseAcquired | +4,912 | $2.02 | +$9,922.24 | 589,696 | Indirect | Duplicate filing |
| Aug 26, 2022 | Common Stock | PPurchaseAcquired | +8,531 | $2.01 | +$17,147.31 | 3,621,100 | Indirect | Duplicate filing |
| Aug 29, 2022 | Common Stock | PPurchaseAcquired | +30,428 | $2.02 | +$61,464.56 | 3,651,528 | Indirect | Duplicate filing |
| Aug 26, 2022 | Common Stock | PPurchaseAcquired | +1,306 | $2.01 | +$2,625.06 | 554,416 | Indirect | Duplicate filing |
| Aug 29, 2022 | Common Stock | PPurchaseAcquired | +4,660 | $2.02 | +$9,413.2 | 559,076 | Indirect | Duplicate filing |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.